Inventor · disambiguated record
Maolin Yu
Also filed as: YU MAOLIN
12 granted patents·8 pending applications·22 citations·filing 2012–2024
86Inventor score
Top patents by PatentIndex Score
20 records- 0193US11046690B2Pyridazinones and methods of use thereofGOLDFINCH BIO INC·Filed 2020·Granted Jun 29, 2021·4 cites·20 claims
- 0290US10654850B2Pyridazinones and methods of use thereofGOLDFINCH BIO INC·Filed 2019·Granted May 19, 2020·4 cites·4 claims
- 0384US2025042901A1Heteroaryl carboxamide compounds as inhibitors of ripk2BOEHRINGER INGELHEIM INT·Filed 2024·Application pending·0 cites
- 0482US9353090B2Heterocyclic carboxylic acids as activators of soluble guanylate cyclaseBOEHRINGER INGELHEIM INT·Filed 2015·Granted May 31, 2016·6 cites·45 claims
- 0579US9334285B2Aldosterone synthase inhibitorsBOEHRINGER INGELHEIM INT·Filed 2015·Granted May 10, 2016·5 cites·42 claims
- 0678US11130754B2Substituted benzamides as RIPK2 inhibitorsBOEHRINGER INGELHEIM INT·Filed 2018·Granted Sep 28, 2021·1 cites·14 claims
- 0775US12139484B2Substituted benzamides as RIPK2 inhibitors for treatment of inflammatory bowel diseaseBOEHRINGER INGELHEIM INT·Filed 2021·Granted Nov 12, 2024·0 cites·23 claims
- 0874US10138241B2Substituted benzamides as RIPK2 inhibitorsBOEHRINGER INGELHEIM INT·Filed 2017·Granted Nov 27, 2018·1 cites·52 claims
- 0967US12466834B2Imidazodiazepinediones and methods of use thereofGFB ABC LLC·Filed 2023·Granted Nov 11, 2025·0 cites·17 claims
- 1067US2022024917A1Pyridazinones and methods of use thereofGOLDFINCH BIO INC·Filed 2021·Application pending·0 cites
- 1164US8815857B2Soluble guanylate cyclase activatorsBOSANAC TODD·Filed 2012·Granted Aug 26, 2014·1 cites·15 claims
- 1252US2023192657A11,2,4-triazolinone cb1 inhibitorsGOLDFINCH BIO INC·Filed 2021·Application pending·0 cites
- 1351US11623930B2Imidazodiazepinediones and methods of use thereofGOLDFINCH BIO INC·Filed 2019·Granted Apr 11, 2023·0 cites·10 claims
- 1449US2022380370A1Xanthine cb1 inhibitorsGOLDFINCH BIO INC·Filed 2020·Application pending·0 cites
- 1548US2022389009A1Substituted 1,6-naphthyridine inhibitors of cdk5GOLDFINCH BIO INC·Filed 2020·Application pending·0 cites
- 1648US2024091303A1Biomarker-based treatment of focal segmental glomerulosclerosis and diabetic kidney diseaseGOLDFINCH BIO INC·Filed 2020·Application pending·0 cites
- 1741US12435078B2Pyridazinones and methods of use thereofGOLDFINCH BIO INC·Filed 2018·Granted Oct 7, 2025·0 cites·10 claims
- 1840US2020377505A1Benzimidazoles and aza-benzimidazoles, and methods of use thereofGOLDFINCH BIO INC·Filed 2018·Application pending·0 cites
- 1940US2022152031A1Pyridazinones and methods of use thereofGOLDFINCH BIO INC·Filed 2020·Application pending·0 cites
- 2039US10131642B1Aldosterone synthase inhibitorsBOEHRINGER INGELHEIM INT·Filed 2016·Granted Nov 20, 2018·0 cites·11 claims
Join the waitlist — get patent alerts
Get an alert when Maolin Yu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →